<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate
Contact Us
Contact Us

Thought Leadership

Two individuals testing materials on lab equipment

1 min read

AGC Biologics Hosts Tours of Viral Vectors Production Facility at Milan site for European Biotech Week 2022

September 1, 2022 at 6:15 AM
Read article
Scientists discussing results of tests.

1 min read

Case Study: How to get from Low Yield to Robust Manufacturing

August 11, 2022 at 10:52 AM
Thought Leadership
Read article
Kayla Bean was featured in Pharma Tech Outlook for R&D innovation.

1 min read

R&D that Increases Speed to Market for Protein Biologics

August 2, 2022 at 4:22 PM
Read article
Longmont campus from drone point of view.

Take a Video Tour of Our New Cell and Gene Longmont Campus

May 20, 2022 at 8:24 AM
Thought Leadership
Read article
CDMO Innovations on Display During World Immunization Week 2022

2 min read

CDMO Innovations on Display During World Immunization Week 2022

April 25, 2022 at 6:00 AM
Thought Leadership
Read article
AGC Biologics CEO discusses company vision

Video: Patricio Massera Discusses AGC Biologics' Growth with Pharma's Almanac

March 25, 2022 at 11:10 AM
Thought Leadership
Read article
AGC Biologics scientist.

1 min read

Webinar: What can plug-and-play offer large-scale AAV manufacturing?

March 16, 2022 at 7:34 AM
Thought Leadership Cell & Gene Therapy
Read article
Patricia Massera quote: Both immuno-oncology and cell and gene therapies have the potential to collide and produce fantastic results.

2 min read

Cancer and Rare Disease: What Progress Can Be Expected in these Fields in 2022 and beyond?

January 14, 2022 at 9:00 AM
Thought Leadership Other Media
Read article
Patricio Massera quote: Research shows that a similar type cell therapy-based personalized medicine, allogenic treatments, holds the potential for quicker, more efficacious, and more accessible therapies

1 min read

Personalized Medicine in 2022: Allogeneic Treatments Can be the Effective “Brick in the Wall” for Cell and Gene Therapy Treatments

January 13, 2022 at 9:00 AM
Thought Leadership Other Media
Read article
Cell and Gene therapy Downstream Process Development

2 min read

AGC Biologics Solves Capacity Shortages in Cell and Gene Therapy Space

October 20, 2021 at 4:15 PM
Events Thought Leadership Cell & Gene Therapy AAV vector manufacturing
Read article
Prev 1 2 3 4 Next